NASDAQ: IVA - Inventiva S.A.

Lønnsomhet i seks måneder: +34.84%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Inventiva S.A.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Inventiva S.A.

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2020-07-10
ISIN US46124U1079
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.inventivapharma.com
Цена ао 3
Prisendring per dag: -0.6667% (3)
Prisendring per uke: -4.18% (3.11)
Prisendring per måned: +24.17% (2.4)
Prisendring over 3 måneder: +21.63% (2.45)
Prisendring over seks måneder: +34.84% (2.21)
Prisendring per år: -25.69% (4.01)
Prisendring over 3 år: -73.46% (11.23)
Prisendring over 5 år: 0% (2.98)
Prisendring over 10 år: 0% (2.98)
Prisendring siden begynnelsen av året: +35.45% (2.2)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 10.36 1
P/BV -6.17 0
P/E 0 0
EV/EBITDA -1.81 0
Total: 3.75

Effektivitet

Navn Betydning Karakter
ROA, % -176.54 0
ROE, % 376.22 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.2841 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 150 10
Lønnsomhet Ebitda, % 272.73 10
Lønnsomhet EPS, % 83.33 9
Total: 9.8
Flere detaljer

Institusjoner Volum Dele, %
Yiheng Capital Management, L.P. 2644926 5.08
NEA Management Company, LLC 1462586 2.81
BVF Inc. 686040 1.32
Commonwealth Equity Services, LLC 36265 0.07
TWO SIGMA SECURITIES, LLC 13005 0.02
Ewa, LLC 11898 0.02
Morgan Stanley 5900 0.01
UBS Group AG 254 0



Veileder Stillingstittel Betaling Fødselsår
Mr. Frederic Cren Co-Founder, CEO & Chairman 521.29k 1966 (59 år)
Dr. Pierre Broqua Ph.D. Co-Founder, Chief Scientific Officer, Deputy CEO & Director 450.22k 1962 (63 år)
Mr. Jean Volatier Deputy GM & CFO N/A 1964 (61 år)
Mr. Eric Duranson L.L.M. General Counsel N/A 1974 (51 år)
Ms. Nathalie Harroy Head of Human Resources N/A 1967 (58 år)
Dr. Michael Cooreman Chief Medical Officer N/A 1958 (67 år)
Ms. Alice Roudot-Ketelers Pharm.D. Chief Operating Officer N/A 1971 (54 år)
Ms. Pascaline Clerc Ph.D. Executive Vice President of Strategy & Corporate Affairs N/A 1980 (45 år)
Dr. Kristina Meyer Ph.D. Executive VP and Business Development & Alliance Management

Adresse: France, Daix, 50 rue de Dijon - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.inventivapharma.com